1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Aquinox Pharmaceuticals Inc. - Product Pipeline Review - 2013

Aquinox Pharmaceuticals Inc. - Product Pipeline Review - 2013

  • October 2013
  • -
  • Global Markets Direct
  • -
  • 27 pages

Aquinox Pharmaceuticals Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Aquinox Pharmaceuticals Inc. - Product Pipeline Review - 2013” provides data on the Aquinox Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Aquinox Pharmaceuticals Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Aquinox Pharmaceuticals Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Aquinox Pharmaceuticals Inc. - Brief Aquinox Pharmaceuticals Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Aquinox Pharmaceuticals Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Aquinox Pharmaceuticals Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Aquinox Pharmaceuticals Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Aquinox Pharmaceuticals Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Aquinox Pharmaceuticals Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Aquinox Pharmaceuticals Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Aquinox Pharmaceuticals Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Aquinox Pharmaceuticals Inc. and identify potential opportunities in those areas.

Table Of Contents

Aquinox Pharmaceuticals Inc. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Aquinox Pharmaceuticals Inc. Snapshot 4
Aquinox Pharmaceuticals Inc. Overview 4
Key Information 4
Key Facts 4
Aquinox Pharmaceuticals Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Aquinox Pharmaceuticals Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Aquinox Pharmaceuticals Inc. - Pipeline Products Glance 9
Aquinox Pharmaceuticals Inc. Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Aquinox Pharmaceuticals Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Aquinox Pharmaceuticals Inc. - Drug Profiles 13
AQX-1000 Series 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
AQX-1125 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
AQX-200 Series 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
AQX-300 Series 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
SHIP1-Inhibitors 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Aquinox Pharmaceuticals Inc. - Pipeline Analysis 18
Aquinox Pharmaceuticals Inc. - Pipeline Products by Therapeutic Class 18
Aquinox Pharmaceuticals Inc. - Pipeline Products By Target 19
Aquinox Pharmaceuticals Inc. - Pipeline Products by Route of Administration 20
Aquinox Pharmaceuticals Inc. - Pipeline Products By Mechanism of Action 21
Aquinox Pharmaceuticals Inc. - Recent Pipeline Updates 22
Aquinox Pharmaceuticals Inc. - Dormant Projects 24
Aquinox Pharmaceuticals Inc. - Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27



List of Tables

Aquinox Pharmaceuticals Inc., Key Information 4
Aquinox Pharmaceuticals Inc., Key Facts 4
Aquinox Pharmaceuticals Inc. - Pipeline by Indication, 2013 6
Aquinox Pharmaceuticals Inc. - Pipeline by Stage of Development, 2013 7
Aquinox Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2013 8
Aquinox Pharmaceuticals Inc. - Phase II, 2013 9
Aquinox Pharmaceuticals Inc. - Phase I, 2013 10
Aquinox Pharmaceuticals Inc. - Preclinical, 2013 11
Aquinox Pharmaceuticals Inc. - Discovery, 2013 12
Aquinox Pharmaceuticals Inc. - Pipeline By Therapeutic Class, 2013 18
Aquinox Pharmaceuticals Inc. - Pipeline By Target, 2013 19
Aquinox Pharmaceuticals Inc. - Pipeline By Route of Administration, 2013 20
Aquinox Pharmaceuticals Inc. - Pipeline Products By Mechanism of Action, 2013 21
Aquinox Pharmaceuticals Inc. - Recent Pipeline Updates, 2013 22
Aquinox Pharmaceuticals Inc. - Dormant Developmental Projects,2013 24



List of Figures

Aquinox Pharmaceuticals Inc. - Pipeline by Indication, 2013 6
Aquinox Pharmaceuticals Inc. - Pipeline by Stage of Development, 2013 7
Aquinox Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2013 8
Aquinox Pharmaceuticals Inc. - Pipeline By Therapeutic Class, 2013 18
Aquinox Pharmaceuticals Inc. - Pipeline Products By Mechanism of Action, 2013 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016 Summary Global Markets ...

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Iduronate 2 Sulfatase (Alpha L Iduronate ...

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016 Summary Global Markets ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.